130 related articles for article (PubMed ID: 37927295)
21. Different power modes of microwave ablation for hepatocellular carcinoma: Evaluation of recurrence rate and factors related to recurrence.
Dong T; Nie F; Liu T; Wang L; Yang D; Yan X
Asian J Surg; 2023 Sep; 46(9):3520-3528. PubMed ID: 37002048
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-guided percutaneous microwave ablation vs. surgical resection for thoracoabdominal wall implants from hepatocellular carcinoma: intermediate-term results.
An C; Hu ZL; Liang P; Cheng ZG; Han ZY; Yu J; Liu FY
Int J Hyperthermia; 2018 Nov; 34(7):1067-1076. PubMed ID: 29161924
[TBL] [Abstract][Full Text] [Related]
23. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
[TBL] [Abstract][Full Text] [Related]
24. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial.
Radosevic A; Quesada R; Serlavos C; Sánchez J; Zugazaga A; Sierra A; Coll S; Busto M; Aguilar G; Flores D; Arce J; Maiques JM; Garcia-Retortillo M; Carrion JA; Visa L; Villamonte M; Pueyo E; Berjano E; Trujillo M; Sánchez-Velázquez P; Grande L; Burdio F
Sci Rep; 2022 Jan; 12(1):316. PubMed ID: 35013377
[TBL] [Abstract][Full Text] [Related]
25. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma.
Medhat E; Abdel Aziz A; Nabeel M; Elbaz T; Zakaria Z; Shousha H; Amer A; Fouad Fathalah W; Maher R; Musa S
J Dig Dis; 2015 Aug; 16(8):456-63. PubMed ID: 25958973
[TBL] [Abstract][Full Text] [Related]
26. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Microwave Ablation Under CT Guidance for Hepatocellular Carcinoma: a Single Institutional Experience.
Pusceddu C; Melis L; Ballicu N; Sotgia B; Melis M; Sanna V; Meloni GB; Porcu A; Fancellu A
J Gastrointest Cancer; 2018 Sep; 49(3):295-301. PubMed ID: 28530021
[TBL] [Abstract][Full Text] [Related]
28. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).
Chong CCN; Lee KF; Cheung SYS; Chu CCM; Fong AKW; Wong J; Hui JWY; Fung AKY; Lok HT; Lo EYJ; Chan SL; Yu SCH; Ng KKC; Lai PBS
HPB (Oxford); 2020 Aug; 22(8):1121-1127. PubMed ID: 32044268
[TBL] [Abstract][Full Text] [Related]
29. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yu Q; Liu C; Navuluri R; Ahmed O
Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation.
Simo KA; Sereika SE; Newton KN; Gerber DA
J Surg Oncol; 2011 Dec; 104(7):822-9. PubMed ID: 21520094
[TBL] [Abstract][Full Text] [Related]
32. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm.
Zheng H; Xu C; Wang X; Li J; Zhao X; Qi J; Feng Y; Zhu Q
Int J Hyperthermia; 2020 Nov; 37(1):1345-1353. PubMed ID: 33289415
[TBL] [Abstract][Full Text] [Related]
33. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
34. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up.
Huang S; Yu J; Liang P; Yu X; Cheng Z; Han Z; Li Q
Eur J Radiol; 2014 Mar; 83(3):552-8. PubMed ID: 24418287
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis.
Han Y; Zhao W; Wu M; Qian Y
Medicine (Baltimore); 2022 Dec; 101(51):e32304. PubMed ID: 36595779
[TBL] [Abstract][Full Text] [Related]
36. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
37. Outcome of Laparoscopic Assisted Percutaneous Microwave Ablation for Exophytic Versus Non-exophytic Hepatocellular Carcinoma.
Mogahed MM; Zytoon AA; Eysa B; Manaa M; Abdellatif W
J Gastrointest Cancer; 2021 Sep; 52(3):892-898. PubMed ID: 32869147
[TBL] [Abstract][Full Text] [Related]
38. Microwave ablation of large HCC lesions: Added value of CEUS examinations for ablation success control.
Pregler B; Beyer LP; Wiesinger I; Nießen C; Jung EM; Stroszczynski C; Wiggermann P
Clin Hemorheol Microcirc; 2016; 64(3):483-490. PubMed ID: 27935548
[TBL] [Abstract][Full Text] [Related]
39. Impact of ablation algorithm versus tumor-dependent parameters on local control after microwave ablation of malignant liver tumors.
Erten O; Li P; Gokceimam M; Akbulut S; Berber E
J Surg Oncol; 2021 Jan; 123(1):179-186. PubMed ID: 32976655
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation.
Li X; Xu M; Liu M; Tan Y; Zhuang B; Lin M; Kuang M; Xie X
Int J Hyperthermia; 2020; 37(1):1016-1026. PubMed ID: 32865050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
